Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa)

NCT06663176 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Cystic Fibrosis Bronchiectasis

Interventions

DRUG: RESP302
DRUG: RESP303

Sponsor

Thirty Respiratory Limited